TITLE

Cerebral paragonimiasis mimicking tuberculoma: First case report in India

AUTHOR(S)
Singh, T. Shantikumar; Khamo, V.; Sugiyama, H.
PUB. DATE
January 2011
SOURCE
Tropical Parasitology;Jan2011, Vol. 1 Issue 1, p39
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
An 8-year-old male child of Tuensang District, Nagaland, India, attended Civil Hospital, Tuensang, complaining of cough, fever, headache, and inability to move right arm since one month. On clinical suspicion of tubercular meningitis, anti-tubercular therapy was initiated and the patient was referred to the Naga Hospital Authority. A brain computed tomography scan revealed an isodense area with surrounding edema on the left parietal lobe, which was diagnosed as tuberculoma and the anti-tubercular therapy was continued. As there was no sign of clinical improvement on completion of the three-month-ATD regimen, the patient was investigated for paragonimiasis. Laboratory investigations revealed peripheral blood eosinophilia, raised ESR, Paragonimus egg-positive sputum, and positive Enzyme-linked immunosorbent assay (ELISA) and ID tests for paragonimiasis. The Bacillus Calmette-Guérin (BCG) test and Acid Fast Bacilli (AFB) sputum smears were negative. Chest roentgenogram showed no abnormal findings. A final diagnosis of pulmonary paragonimiasis associated with cerebral paragonimiasis was made. The patient responded to praziquantel therapy. Cerebral paragonimiasis is a serious extrapulmonary form of paragonimiasis, sometimes life-threatening, but curable with praziquantel. It should be included in the differential diagnosis of cerebral granulomatous and other space-occupying lesions.
ACCESSION #
60878466

 

Related Articles

  • Different clarithromycin doses affect mortality.  // AIDS Patient Care & STDs;Apr97, Vol. 11 Issue 2, p102 

    Reports on the Terry Beirn Community Program's comparative study on the efficacy and safety of four regimens for disseminated microbacterium avium complex (MAC). Interim analysis; Increased rate of mortality; Discontinuance of use.

  • Paragonimiasis in Chinese Children: 58 Cases Analysis. Hong Zhen Xu; Lan Fang Tang; Xiao Ping Zheng; Zhi Min Chen // Iranian Journal of Pediatrics;Dec2012, Vol. 22 Issue 4, p505 

    Objective: To analyze the clinical and radiological features of paragonimiasis in children and raise the awareness of this disease. Methods: A total of 58 paragonimiasis patients were reviewed. They were 42 boys and 16 girls aged 2.0 to 15.3 years. Findings: Among these patients, 20 were...

  • The Hunt for New Tuberculosis Vaccines: Anti-TB Immunity and Rational Design of Vaccines. Zhou Xing // Current Pharmaceutical Design;Jul2001, Vol. 7 Issue 11, p1015 

    Tuberculosis (TB) remains to be a leading infectious cause of death Worldwide. Apparently, the current BCG vaccine that has been used for 80 years, has failed to control the TB epidemic. Hunting for improved TB vaccine formulations represents a daunting task to TB research community. Anti-TB...

  • Resistance to antituberculosis drugs.  // Weekly Epidemiological Record;5/12/2000, Vol. 75 Issue 19, p156 

    Focuses on the standardization of the surveillance of resistance to antituberculosis drugs in European Union countries. Dissemination of epidemiological information on tuberculosis; Variation in proportion of isolates with drug resistance; Selection of drug-resistant mutant bacilli.

  • European recommendations on surveillance of antituberculosis drug resistance.  // Weekly Epidemiological Record;1/5/2001, Vol. 76 Issue 1, p2 

    Provides recommendations on surveillance of antituberculosis drug resistance in Europe. Definition of multi-drug resistance (MDR); Treatment of MDR tuberculosis patients; Prevalence of antituberculosis drug resistance in the country.

  • Combination TB drug approved.  // FDA Consumer;Sep94, Vol. 28 Issue 7, p2 

    Comments on approval by the Food and Drug Administration (FDA) of Rifater, a product that combines three existing tuberculosis drugs into a single tablet. Why this fixed-dose product was developed.

  • Inhibition of Pyrazinamide Hyperuricemia by Small Doses of Acetylsalicylic Acid. Petty, Thomas L.; Dalrymple, Glenn V. // Annals of Internal Medicine;May64, Vol. 60 Issue 5, p898 

    Studies the effect of small doses of acetylsalicylic acid on hyperuricemia associated with the antituberculous drug pyrazinamide. Mechanism of the drug's paradoxicaL effect; Effectiveness of acetylsalicylic acid in controlling serum uric acid levels.

  • tuberculostatic.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2385 

    A definition of the medical term "tuberculostatic," which refers to inhibiting the growth of tubercle bacillus, is presented.

  • antitubercular.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p155 

    The medical definition of the term "antitubercular" is presented, which refers to inhibiting or treating tuberculosis, or a substance used to inhibit or treat tuberculosis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics